Patent Yard Sign in
Canadian application, no grantCanada

Antibody testing method and antigen microarray

CA 2390983 A1 · Owner: Ezaki, Takayuki · Inventors: Ezaki, Takayuki

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for testing whether or not an antibody that binds with any of a plurality of target antigens is contained in a test sample. In this method, a test sample is contacted with an antigen microarray having spots of at least eight types of target antigens. In the case the test sample contains an antibody corresponding to the target antigens that antibody is retained on the antigen microarray by an antigen-antibody reaction. A labeled secondary antibody labeled with a fluorescent pigment is then contacted with the antigen microarray. Fluorescence of the labeled secondary antibody is then detected by a detection device such as a laser fluorescent microscope or laser scanner.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 19, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 19, 2002
GrantedNo grant recorded
Term endedJune 19, 2022
Patent numberCA 2390983 A1
Classification (IPC)G01N33/68 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJune 19, 2002Term endedJune 19, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.